Quick Search:         Advanced Search
Chinese Version
Online office
Journal Online
Download
Top
Links
阮秋蓉,宋建新,邓仲端,瞿智玲.山莨菪碱对血管内皮细胞组织因子和纤溶酶原激活物抑制剂1表达的影响及其机制研究[J].,2004,(5):422-426
山莨菪碱对血管内皮细胞组织因子和纤溶酶原激活物抑制剂1表达的影响及其机制研究
Study on Effect of Anisodamine on Expressions of Tissue Factor and Plasminogen Activator-1 Inhibitor in Vascular Endothelial Cells and Its Mechanisms
  
DOI:
中文关键词:  山莨菪碱  内毒素  血管内皮细胞  组织因子  纤溶酶原激活物抑制剂1  核因子-кB
英文关键词:anisodamine  endotoxin  vascular endothelial cell  tissue factor  plasminogen activator inhibitor type 1  nuclear factor-кB
基金项目:国家自然科学基金资助项目(No.39730220);武汉市科委晨光计划项目(No 985003086)
Author NameAffiliation
RUAN Qiu-rong 华中科技大学同济医学院病理学教研室 
SONG Jian-xin 同济医学院附属同济医院 
DENG Zhong-duan 华中科技大学同济医学院病理学教研室 
瞿智玲 华中科技大学同济医学院病理学教研室 
Hits: 1390
Download times: 1879
中文摘要:
      目的 通过研究山莨菪碱对内毒素脂多糖(LPS)致血管内皮细胞组织因子(TF)和纤溶酶原激活物抑制剂1(PAI-1)表达的影响,探讨山莨菪碱治疗感染性休克的机制。方法 用酶消化法培养人脐静脉内皮细胞(HUVEC);ELISA方法检测HUVEC条件培养液PAI-1蛋白量:用一步凝固法检测HUVEC TF活性;Northern blot检测HUVEC TF和PAI-1的mRNA表达;为了评估上述作用是否通过NF-кB途径而转导,用电泳迁移变动检测法(EMSA)检测HUVEC核提取物NF-кB DNA结合活性。结果 LPS能使HU-VEC PAI-1蛋白和TF活性及其mRNA表达显著增强,加入山莨菪碱后,LPS的这种作用明显减弱,并与山莨菪碱呈量效关系。山莨菪碱能完全阻止LPS致内皮细胞核提取物NF-кB DNA结合活性。结论 山莨菪碱治疗感染性休克的机制之一可能是通过拮抗LPS致HUVEC TF和PAI-1的表达。而且这种拮抗作用可能通过NF-кB途径来转导。
英文摘要:
      To explore the mechanism of anisodamine in treating infectious shock through studying effect of anisodamine on endotoxin lipopolysaccharide (LPS) induced expression of tissue factor (TF) and plasminogen activator inhibitor type 1 (PAI-1) in vascular endothelial cells (EC). Methods Human umbilical vein endothe-lial cells (HUVEC) were cultured by trypsin digestion method. PAI-1 was measured in the conditioned medium of HUVEC by a specific enzyme-linked immunosorbent assay (ELISA), whereas TF activity was measured in the lysates of these cells by using a single step clotting assay. Specific mRNA expressions were determined by Northern blotting. In order to evaluate a possible contribution of the nuclear factor-kappa B (NF-кB) pathway on the transductive effects observed, electrophoretic mobility shift assays (EMSA) were performed using nuclear extracts from HUVEC and NF-кB binding oligonucleotides. Results LPS could significantly strengthen the expression of HUVEC PAI-1 protein and TF activity and its mRNA, this effect of LPS could be markedly weakened after adding Anisodamine dose-dependently. Anisodamine could also completely block the LPS induced NF-кB DNA binding activity in nuclear extracts from HUVEC. Conclusion The possible mechanism of anisodamine in treating infectious shock may be through antagonizing LPS induced HUVEC TF and PAI-1 expression, and the antagonism might be, at least partially, transduced by path of NF-кB.
View Full Text  View/Add Comment  Download reader